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ABSTRACT
Introduction: Obesity is increasingly prevalent among
patients undergoing surgery. Conflicting evidence
exists regarding the impact of obesity on postoperative
complications. This multicentre study aims to
determine whether obesity is associated with increased
postoperative complications following general surgery.
Methods and analysis: This prospective, multicentre
cohort study will be performed utilising a collaborative
methodology. Consecutive adults undergoing open or
laparoscopic, elective or emergency, gastrointestinal,
bariatric or hepatobiliary surgery will be included. Day
case patients will be excluded. The primary end point
will be the overall 30-day major complication rate
(Clavien-Dindo grade III–V complications). Data will be
collected to risk-adjust outcomes for potential
confounding factors, such as preoperative cardiac risk.
This study will be disseminated through structured
medical student networks using established
collaborative methodology. The study will be powered
to detect a two-percentage point increase in the major
postoperative complication rate in obese versus non-
obese patients.
Ethics and dissemination: Following appropriate
assessment, an exemption from full ethics committee
review has been received, and the study will be
registered as a clinical audit or service evaluation at
each participating hospital. Dissemination will take
place through national and local research collaborative
networks.
BACKGROUND
Obesity has reached ‘epidemic’ levels across
the world, challenging healthcare systems
and economies in developed and developing
countries. Obesity rates in the UK have risen
dramatically in the last decade, from 13.2%
to 24.4% in males, and 16.4% to 25.1% in
females.1 In UK surgical practice, 30% of
patients are identiﬁed as obese.2
Obesity is a known risk factor for several
medical morbidities, including cardiovascu-
lar disease and diabetes. It has also been
associated with an increased risk of several
malignancies, including cancer of the colon
and oesophagus.3 Conﬂicting evidence exists
regarding the impact of obesity on post-
operative complications following gastrointes-
tinal surgery. A study of over 6 000 patients
demonstrated no difference in mortality and
postoperative morbidity for obese and non-
obese patients.4 Recent studies have identi-
ﬁed an obesity paradox, with moderate
obesity offering protection from adverse
events, whereas underweight patients are at
greater risk.5 6 However, other reports have
suggested obesity is associated with an
increased risk of surgical-site infection and
venous thromboembolism.7–9
The need for further evidence
Most studies exploring the role of obesity in
determining postoperative complication rates
have either been single centre, retrospective
cohort studies or secondary analyses of previ-
ously collected data. There is a need for a
multicentre prospective study that is primar-
ily designed to address whether obesity is
associated with an increased risk of post-
operative complications. Detailed patient
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background should be collected in order to risk-adjust
outcomes for potential confounders such as preopera-
tive cardiac risk and socioeconomic status.
Primary aim
The primary aim of the Determining Surgical
Complications in the Overweight (DISCOVER) study is
to determine whether obesity is associated with an
increased risk of postoperative complications following
gastrointestinal, bariatric and hepatobiliary surgery.
Hypothesis
The 30-day major postoperative complication rate, fol-




A national multicentre prospective cohort study dissemi-
nated through collaborative university medical school
and student networks (ﬁgure 1). The generic collabora-
tive methodology has been described previously.10
The STARSurg network
Student Audit and Research in Surgery (STARSurg) is
the UK’s national medical student research collaborative
coordinated by a team of medical students and supervi-
sors. Given common problems faced by students wishing
to engage in high-quality extracurricular academic pro-
jects,11 the STARSurg network was formed to empower
participation by forming links with supervising junior
doctors and consultants. Through this, students contrib-
ute data to national studies while gaining an understand-
ing of clinical academia, audit and research
methodology and ethical considerations. This network
facilitates multicentre, student-led audit and research
projects with the ultimate aim of engaging students early
in academic projects in order to help embed audit and
research as a fundamental aspect of routine clinical
practice. The educational model used and the beneﬁts
that participating students can derive from this have
been described previously.12
The STARSurg network has previously delivered the
world’s ﬁrst student-led multicentre study. Over 250
medical students and 100 junior doctors participated
across 109 hospital centres to collect data on over 1500
patients undergoing gastrointestinal resection to investi-
gate non-steroidal anti-inﬂammatory drugs (NSAIDs) as
risk factors for postoperative adverse events.13 The spe-
ciﬁc methodology for this network has been previously
described in the literature.14
Study setting
This study will take place in general surgical units in
state (publically funded) hospitals in the UK and the
Republic of Ireland. Any hospital performing elective or
emergency gastrointestinal, bariatric or hepatobiliary
surgery may participate. Each centre will contribute up
to three 2-week sets of consecutive patient data.
Inclusion criteria
▸ Consecutive adult patients undergoing gastrointes-
tinal, bariatric or hepatobilliary surgery.
▸ Patients undergoing either elective or emergency,
and open, laparoscopic, laparoscopic-assisted or
laparoscopic-converted procedures may be included.
Exclusion criteria
▸ Patients under 18 years of age
▸ Day case surgery (ie, patients without an overnight
hospital stay immediately preceding or following their
operation)
▸ Hernia surgery, unless bowel resection is performed
▸ Minor anorectal procedures, unless there is an
abdominal or laparoscopic approach
▸ Transplant surgery
▸ Trauma indication
▸ Gynaecological primary indication
▸ Urological primary indication
▸ Vascular primary indication
The primary end point of DISCOVER is major post-
operative complications requiring reoperation,
unplanned admission to intensive care or resulting in
death. To ensure accurate case ascertainment, collabora-
tors’ workloads have been rationalised by only including
those procedures that commonly result in major compli-
cations. Consequently, low-risk day case, hernia and ano-
rectal surgery have been excluded.
The audit standard in this study is that all patients
should have their body mass index (BMI), calculated on
admission to hospital, reﬂecting current guidelines from
the National Institute for Health and Care Excellence
(NICE).15
Primary outcome measure
The primary outcome measure will be the 30-day major
postoperative complication rate. Major complications will
be deﬁned as Clavien-Dindo grade III–V complications.
The Clavien-Dindo classiﬁcation has been selected as the
primary outcome measure as it is a clinically relevant, an
internationally standardised and validated scoring system
for postoperative complications (table 1).16 It is based on
the interventions required to treat complications, taking
a holistic account of clinically signiﬁcant events.
Secondary outcomes
Secondary outcome measures will be rates of system-
speciﬁc complications (table 2), unplanned admission
to the critical care unit, reoperation and readmission.
Explanatory variables
BMI is the main explanatory variable. Patients will be
stratiﬁed by BMI; underweight (BMI <18.5), healthy
weight (BMI 18.5–24.99), overweight (BMI 25–29.99)
and obese (BMI ≥30). The American Society of
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Anaesthesiologists (ASA) score will be recorded for each
patient to adjust for global comorbidity status. Smoking
history will be recorded and the Revised Cardiac Risk
Index will be calculated for each patient to adjust for
pre-existing cardiovascular risk (box 1).17 The
Malnutrition Universal Screening Tool (MUST)18 and
Nutritional Risk Index19 will be calculated to adjust for
nutritional status. The Index of Multiple Deprivation
(IMD) will be recorded to adjust for socioeconomic
status. Procedures will be classiﬁed according to their
operative complexity as per the British United Provident
Association (BUPA) schedule of procedures.17
Patient identification and data collection
Collaborators will be asked to screen operating lists for
eligible patients daily or as frequently as is practically pos-
sible. The patient demographics and operative data ﬁelds
should be completed as soon as the patient is identiﬁed
as being eligible to be included in DISCOVER.
Collaborators will be encouraged to regularly monitor
patients for complications in the postoperative period.
The follow-up ﬁelds should be collected as soon as pos-
sible after the end of the 30-day follow-up.
Quality assurance
Although, many collaborators participating in the study
will be medical students, each local team must include at
least one qualiﬁed doctor to oversee and supervise the
students. The study will additionally be registered with a
sponsoring consultant surgeon at each hospital site.
A detailed protocol describing how to register and run
the study will be made available to collaborators online
and by email. This will describe in detail the inclusion
and exclusion criteria, along with examples. Possible
follow-up strategies will be discussed. The principles
underlying the Clavien-Dindo classiﬁcation will be
explained with examples. The protocol will also include
an indepth description of data ﬁelds and the potential
data sources which collaborators could use to collect
them. The protocol will be interactively presented at a
national collaborator meeting and at local collaborator
meetings organised by the study’s regional leads.
Feedback from these meetings will be used to clarify any
ambiguities in the protocol.
To overcome the learning curve in identifying patients
and relevant data, all participating centres will be asked
to pilot completing patient identiﬁcation and the initial
stages of the data collection form for 1 day in the week
leading up to the main study’s starting date.
To ensure collaborators understand the inclusion cri-
teria and application of the Clavien-Dindo classiﬁcation,
they will be asked to complete a case-based online
e-learning module prior to starting data collection.
To ensure that the primary outcome is accurately
recorded, the Clavien-Dindo grade for each complication
experienced by a patient will be independently assessed
by two collaborators. Any disagreements will be resolved
by discussion with other members or supervisors.
Throughout the data collection period, the trial man-
agement group will hold weekly Twitter question and
answer sessions (https://twitter.com/STARSurgUK),
giving the opportunity for collaborators to clarify any
uncertainties regarding the protocol. A summary of fre-
quently asked questions will be distributed to all colla-
borators following each Twitter session, providing near
real-time feedback to collaborators.
Figure 1 STARSurg ‘Mini-Team’ structure, roles and responsibilities.
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Validation
Following data collection, only data sets with >95% data
completeness will be accepted for pooled national ana-
lysis. An independent assessor will validate 5% of all data
points, with a target of >95% case ascertainment and
>98% data accuracy.
Data management
Data will be collected and stored online through a
secure server running the Research Electronic Data
Capture (REDCap)20 web application hosted at the
University of Edinburgh. REDCap is a secure, web-based
application designed to support data capture for
research studies by providing: (1) an intuitive interface
for validated data entry; (2) audit trails for tracking data
manipulation and export procedures; (3) automated
export procedures for seamless data downloads to
common statistical packages; and (4) procedures for
importing data from external sources. It is widely used
internationally by academic organisations to store
research databases. Collaborators will be given secure
login details, including a password for the REDCap
project server. All transmission and storage of web-based
information by this system is encrypted. Any patient
identiﬁable information will not be available for
data-analysis and will be automatically stripped from the
database when exported from REDCap.
Anticipated minimum recruitment
It is estimated that an average centre performs approxi-
mately 40 gastrointestinal and hepatobiliary cases, thus
meeting the study inclusion criteria in a 28-day period.
A minimum of 148 centres will be recruited, with at least
four centres participating at each of 37 medical schools.
Overall, we anticipate recruiting at least 5920 patients in
total.
Power calculation
This study is powered to detect a signiﬁcant difference
between obese patients (BMI ≥30) and patients with
healthy weight (BMI 18.5–24.99). A total of 3550
patients would provide 80% power to detect a 35%
increase in the postoperative complication rate from 8%
to 10.8% (α=0.05, matched 1 experimental (n=1775): 1
control (n=1775), power=0.80).
Statistical analysis
Differences between demographic groups will be tested
with the χ2 test. Multivariable binary logistic regression
will be used to test the inﬂuence of clinically plausible
variables on the outcome measures, to produce adjusted
ORs and bootstrapped 95% CIs. This will be performed
ﬁrst on the whole dataset and then a matched group of
1:1 control (healthy weight): experimental (obese),
using propensity scoring. Data handling will be per-
formed in SPSS V.21.0 and statistical modelling in the R
Foundation Statistical Programme V.3.0.0.
ETHICS AND DISSEMINATION
Research ethics approval
Following review of the study protocol by a Research
Ethics Committee Chairperson and a University NHS
Trust Research & Development Ofﬁce Director, the
authors were advised that this observational study can be
undertaken as a clinical audit and does not require
formal ethical review. Caldicott guardian approval was
Table 1 The Clavien-Dindo classification of postoperative complications
Grade Definition (examples listed in italics)
I Any deviation from the normal postoperative course without the need for pharmacological (other than the ‘allowed
therapeutic regimens’), surgical, endoscopic or radiological intervention
Allowed therapeutic regimens are: selected drugs (antiemetics, antipyretics, analgesics, diuretics and electrolyte
replacement), physiotherapy and wound infections opened at the bedside but not treated with antibiotics
Examples: Ileus (deviation from the norm); hypokalemia treated with sando K; nausea treated with cyclizine; acute
kidney injury treated with intravenous fluids
II Requiring pharmacological treatment with drugs beyond those allowed for grade I complications. Blood transfusions
and total parenteral nutrition are also included
Examples: Surgical site infection treated with antibiotics; myocardial infarction treated medically; Deep venous
thrombosis treated with enoxaparin; pneumonia or urinary tract infection treated with antibiotics; blood transfusion for
anaemia
III Requiring surgical, endoscopic or radiological intervention
Examples: Return to theatre for any reason; therapeutic endoscopic therapy (do not include diagnostic procedures);
interventional radiology procedures
IV Life-threatening complications requiring critical care management; neurological complications including brain
haemorrhage and ischaemic stroke (excluding TIA).
Examples: Single or multiorgan dysfunction requiring critical care management, e.g. pneumonia with ventilator
support, renal failure with filtration; SAH; stroke
V Death of a patient
TIA, transient ischaemic attack.
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Table 2 System-specific complication outcome measures
Cardiovascular
Angina (exacerbation) Increase in chest pain requiring start or increase of medications
Arterial thrombosis/embolism Include peripheral arterial thrombosis or embolism (not including stroke) (not
including stroke) demonstrated by CT, MRI or angiography
Arrythmia Any cardiac arrhythmia demonstrated on an ECG, except sinus tachycardia and
sinus arrhythmia
Hypertension Increase in systolic blood pressure requiring start or increase of medications
Myocardial ischaemia Include ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial
infarction (NSTEMI) and unstable angina. Diagnosis must have been confirmed
following review of the patient by a cardiologist/on-call medical team
Venous thrombosis, deep vein
thrombosis (DVT)
Peripheral venous thrombosis demonstrated by ultrasound, CT, MRI or angiography
Venous thrombosis, other Venous thrombosis of the abdominal venous systems, including the coeliac, splenic,
hepatic and mesenteric veins. Thrombosis should be demonstrated by CT or MRI
Metabolic
Hypoglycaemia Low blood sugar requiring intervention
Hyperglycaemia High blood sugar requiring increase or start of new medications
Hypokalaemia Low serum potassium requiring intervention
Hyperkalaemia High serum potassium requiring intervention
Hypomagnesaemia Low serum magnesium requiring intervention
Hyponatraemia Low serum sodium requiring intervention. Include syndrome of inappropriate
antidiuretic hormone secretion (SIADH)
Hypernatraemia High serum sodium requiring intervention
Hypophosphatemia Low serum phosphate requiring intervention
Neurological
Head injury Include extradural haemorrhage, subdural haemorrhage, subarachnoid
haemorrhage, cerebral contusion demonstrated on CT or MRI
Stroke/TIA, Include transient ischaemic attack (TIA), ischaemic or haemorrhagic stroke.
Diagnosis must have been confirmed following review of the patient by a stroke
physician/on call medical team
Renal
Acute kidney injury Acutely deranged renal function, with serum creatine increased to at least 1.5 times
greater than the most recent preoperative baseline
Urinary retention Failure to pass urine, requiring urinary catheterisation
Urinary tract infection (UTI) The patient has had clinical evidence of urinary tract infection. UTI must be proven
by mid-stream/catheter specimen culture
Respiratory
Acute respiratory distress syndrome
(ARDS)
Respiratory failure not explained by cardiac failure or fluid overload, with chest
radiograph or CT scan demonstrating bilateral opacities not fully explained by
effusions, lobar/lung collapse or nodules
Atelectasis Collapse of part of the lung, confirmed by chest X-ray or CT scan
Haemothorax Presence of blood in the pleural space, confirmed by chest X-ray or CT scan
Pleural effusion Presence of fluid in the pleural space, confirmed by chest X-ray or CT scan
Pneumonia, aspiration Pulmonary inflammation caused by infection, confirmed by chest X-ray or CT scan.
Include pneumonias thought to be caused by aspiration of feed or fluid in to the lungs
Pneumonia, hospital acquired Pulmonary inflammation caused by infection, confirmed by chest X-ray or CT scan.
Include all pneumonias other than aspiration pneumonias
Pneumothorax Presence of gas in the pleural space, confirmed by chest X-ray or CT scan
Pulmonary embolus Include pulmonary emboli (PE) confirmed by CT pulmonary angiogram (CTPA) or
ventilation/perfusion (V/Q) scans
Pulmonary oedema Fluid accumulation in the lung parenchyma, confirmed by chest X-ray or CT scan
Surgical
Abscess Collection of fluid containing pus. Include any intra-abdominal or intrapelvic abscess,
detected clinically, by ultrasound or CT scan and/or intraoperatively
Anastomotic leak Include all anastomotic leaks. Include leaks detected by CT scan and/or
intraoperatively; and leaks managed conservatively or surgically
Bile duct injury Intraoperative injury to the bile ducts requiring further postoperative management
Bile leak Include all bile leaks. Include leaks detected by CT scan and/or intraoperatively; and
leaks managed conservatively or surgically
Bladder injury Intraoperative injury to the bladder requiring further postoperative management
Continued
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granted to store patient data. This study will be regis-
tered as clinical audit or service evaluation at each par-
ticipating hospital.
Protocol dissemination
The protocol will be disseminated primarily through
medical student networks, including student surgical
and medical societies. Postgraduate research collabora-
tives and the Association of Surgeons in Training
(http://www.asit.org) will also disseminate the protocol
to their members. A student local lead will be desig-
nated at each medical school to facilitate local dissemin-
ation. The protocol document will be made available
online and will also be disseminated through social
media, including Twitter (https://twitter.com/
STARSurgUK) and Facebook (https://www.facebook.
com/STARSurgUK). The novel use of social media to
drive collaborator recruitment by the STARSurg collab-
orative has been described previously.21
DISCUSSION
The study described in this protocol will assess the
health needs of an increasing population of surgical
patients for whom current surgical outcome data are
conﬂicting. It will provide a prospective snap-shot to
inform priorities in the perioperative management of
obese surgical patients. Should obese patients be found
Chylothorax Presence of lymphatic fluid in the pleural space, confirmed by chest X-ray or CT
scan
Clostridium difficile C. difficile infection must be confirmed by detection of C. difficile toxin in faeces
Enterotomy Accidental surgical incision in to the bowel. Include leaks from enterotomies detected
by CT scan and/or intraoperatively; and leaks managed conservatively or surgically
Haematoma Collection of fluid-containing blood, diagnosed clinically or by ultrasound or CT scan
Haemorrhage, reactionary Haemorrhage from operative sites within 48 h of operation
Haemorrhage, secondary Haemorrhage from operative sites after 48 h of operation
Ileus Delay to return to normal gut function, defined as intolerance to solid food and/or
failure to pass flatus >3 days following operation
Ischaemic colitis Inflammation of the colon caused by inadequate blood supply, diagnosed clinically,
by CT scan and/or intraoperatively
Postoperative nausea Postoperative nausea requiring intervention
Seroma Collection of serous fluid, diagnosed clinically or by ultrasound or CT scan
Splenic injury Intraoperative injury to the spleen requiring further postoperative management
Upper gastrointestinal (upper GI)
bleed
Include upper GI bleed of any aetiology other than haemorrhage from operative sites
(select ‘haemorrhage, reactionary/secondary’ for these)
Ureteric injury Intraoperative injury to the ureters requiring further postoperative management
Wound dehiscence Rupture of a surgical wound along the suture line
Wound infection We advise adherence to the Centre for Disease Control’s definition of surgical site
infection, which is any one of:
▸ Purulent drainage from the incision
▸ At least two of: pain or tenderness; localised swelling; redness; heat; fever; AND
The incision is opened deliberately to manage infection or the clinician diagnoses
a surgical site infection
▸ Wound organisms AND pus cells from aspirate/swab
Miscellaneous
Blood stream infection An infection not related to infection at another site, with a recognised pathogen
cultured from blood cultures which is not related to an infection at another site
Cellulitis Bacterial infection involving the skin
Central line infection Infected peripherally inserted central catheter (PICC) or central lines, confirmed by
culture of line tip
Fracture Any fracture sustained postoperatively, diagnosed by plain film X-ray, CT or MRI
Peripheral line infection Localised cellulitis (erythaema and swelling) around a peripheral cannula insertion
site
Pressure sore Decubitus ulcers, localised injuries to the skin and/or underlying tissue as a result of
pressure usually over a bony prominence
Other Please enter free text
Box 1 The revised cardiac risk index
Revised Cardiac Risk Index
1. History of ischaemic heart disease
2. History of congestive heart failure
3. History of cerebrovascular disease (stroke or transient ischae-
mic attack)
4. History of diabetes requiring preoperative insulin use
5. Chronic kidney disease (creatinine >177 mmol/L)
6. Undergoing suprainguinal vascular, intraperitoneal, or
intrathoracic surgery
Table 2 Continued
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to be at increased risk of postoperative complications,
this would demonstrate a need for the development of
novel interventions to reduce this risk.
This study has been designed to be delivered through
a national student network, with the aim of engaging
students with multicentre studies. To maximise recruit-
ment to the study it has been designed to be registered
as clinical audit or service evaluation. To facilitate this, a
pragmatic approach was adopted, most importantly
ensuring that the study is purely observational. The pro-
ject’s complexity does warrant a detailed protocol to
ensure consistency and reproducibility across all the
centres participating in data collection.
The limitations of this study relate to the observational
methodological design. Being unable to proactively
gather anthropometric data, we expect that BMI values
will be unavailable for a proportion of patients. Equally
it is inevitable that there will be some missing data;
however, only 1.5% of patients in our previous collabora-
tive study had missing data.11 To attempt to maximise
data completeness, regular reminders will be sent to col-
laborators with ongoing assistance from supervisors to
ensure available data is not missed.
Collaborators will rely on clear documentation of com-
plications in the medical notes and discharge letters to
identify morbidity in the follow-up period. Since minor
complications are not always consistently documented, it is
likely that DISCOVER may underestimate the incidence of
some complications. However, DISCOVER will offer a com-
prehensive overview of all postoperative events and this
depth of data will overcome some of these limitations.
An observational study is unlikely to deﬁnitively prove
causation between obesity and morbidity; however,
DISCOVER is likely to present the best quality of evidence
available on this topic. Importantly, DISCOVER will gener-
ate the data necessary to power any future clinical trials
aiming to provide grade 1 evidence in this arena.
This project will aid the continued development of the
STARSurg collaborative network, with the addition of more
centres, including hospitals in the Republic of Ireland. As
the network continues to mature, it will develop the infra-
structure to deliver interventional studies whose design
would be informed by this observational study.
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